CIENCIASMEDICASNEWS: Lentivirus-based alternatives to SARS-CoV2 live-virus restrictions

viernes, 19 de junio de 2020

Lentivirus-based alternatives to SARS-CoV2 live-virus restrictions

	Infectious Diseases
	The latest infectious diseases news from News Medical

Lentivirus-based alternatives to SARS-CoV2 live-virus restrictions

Work with the convenience of ready to use, pre-made lentiviruses. Developed specifically with the intent of studying biochemical and cell-based interactions, lentiviruses, inhibition assays and cell lines are used to monitor pathway activation, rapidly screen entry inhibitors and evaluate vaccine-induced neutralizing antibodies against the highly pathogenic SARS-CoV2.

Find Out More

Specially Designed Proteins for COVID-19 Serological Test Development

Customized formulation and functionality confirmed S1, S RBD mutants, and N proteins are available for bulk order.

Learn More

Specific immune suppression leads to severe COVID-19 disease

A new study published online on the preprint server medRxiv in May 2020 reports that specific changes in the way the human immune system responds to COVID-19 determine whether the individual develops moderate or severe illness.

	Researchers identify a new subset of cells involved in immune response against hepatitis B For the first time, researchers at The Westmead Institute for Medical Research have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) infection. The discovery could help develop new treatments for HBV and inform future vaccine design.

	Identifying the Starting Points for COVID19 Treatment News-Medical spoke to researchers from the German Primate Center on their research in determining the activation sequence of the SARS-CoV-2 virus.

	Inhibiting host cell proteases can help prevent COVID-19 infection How can we prevent the novel coronavirus from invading a host cell in an attempt to prevent infection?

	CD8+ T cells can help develop vaccines against Japanese encephalitis, Zika fever A clinical case of Japanese encephalitis is diagnosed in over 68,000 individuals every year, leading to the death of one in four of these affected patients.